Some authors noted a decrease of its representation in IBD and even suggested the use of Akkermansia muciniphila as a new generation probiotics [9,78,79,80], while others showed its increase in the microbiota of CD patients and suggested that it degrades the mucin of the intestinal mucosa, thereby provoking its inflammation [8]. The gene discussed is MUC5AC; the disease is inflammatory bowel disease.